Reviving matrix (anti-gliotic guiding regenerative gel) for reconstruction of severely injured peripheral nerve and spinal cord


  • Rochkind Shimon Research Center for Nerve Reconstruction, Tel Aviv Sourasky Medical Center,Tel Aviv University, Israel
  • Almog Mara Research Center for Nerve Reconstruction, Tel Aviv Sourasky Medical Center, Israel
📧Corresponding author


Peripheral nerve injury (PNI) leads to partial or complete paralysis, severe pain, disabilities and deterioration in quality of life. PNI occurs in about 2.8% of all trauma patients. Incidence of nerve injuries is 13.9/100,000 inhabitants per year. The innovative Anti-gliotic Guiding Regenerative Gel (AGRG) is a special milieu that increases nerve growth and promotes recovery, aiming, ultimately, at restoring the function of an injured peripheral nerve and enable spinal cord repair. The AGRG is composed of: 1) anti-oxidant, found to protect cells from oxidative stress, regulating immune function, maintaining endothelial cell integrity; 2) proprietary peptide (16 amino acids) based on the active sites of laminin peptide and containing two penta-peptides, which acts as a scaffold for the nerve fibers to grow along; 3) hyaluronic acid, which is highly hydrated and contributes to the success of survival, growth and regeneration of nerve fibers by protecting them from drying; and 4) copaxone is an immunomodulatory and neuroprotective drug. These results show that treatment with AGRG was active in enhancing spinal repair in both acute and chronic SCI models in rats; highlighting that AGRG\'s superiority in promoting neuronal regeneration. AGRG opens a new modality in treatment of injured nerves, enabling the introduction of composite implant, with decreased time and improved quality of recovery, for clinical applications.


AGRG nerve rat spinal cord injury

Download pdf


  1. Rochkind S, Shahar A, Alon M, Nevo Z. Transplantation of embryonal spinal cord nerve cells cultured on biodegradable microcarriers followed by low power laser irradiation for the treatment of traumatic paraplegia in rats. Neurol Res [Internet]. 2002 Jun 19; 24 (4): 355-60. DOI: [PMid:12069281]
  2. Rochkind S, Astachov L, El-Ani D, Hayon T, Graif M, Barsky L, et al. Further development of reconstructive and cell tissue-engineering technology for treatment of complete peripheral nerve injury in rats. Neurol Res [Internet]. 2004 Mar 19; 26 (2): 161-6. DOI: [PMid:15072635]
  3. Rochkind S, Shahar A, Fliss D, El-Ani D, Astachov L, Hayon T, et al. Development of a tissue-engineered composite implant for treating traumatic paraplegia in rats. Eur Spine J [Internet]. 2006 Feb 15; 15 (2): 234-45. DOI: [PMid:16292587 PMCid:PMC3489403]
  4. Rochkind S, Nevo Z. Recovery of Peripheral Nerve with Massive Loss Defect by Tissue Engineered Guiding Regenerative Gel. Biomed Res Int [Internet]. 2014 Feb 15; 2014 (2): 1-7. DOI: [PMid:25105121 PMCid:PMC4106053]
  5. Shapira Y, Tolmasov M, Nissan M, Reider E, Koren A, Biron T, et al. Comparison of results between chitosan hollow tube and autologous nerve graft in reconstruction of peripheral nerve defect: An experimental study. Microsurgery [Internet]. 2016 Nov 15; 36 (8): 664-71. DOI: [PMid:25899554]
  6. Meyer C, Wrobel S, Raimondo S, Rochkind S, Heimann C, Shahar A, et al. Peripheral Nerve Regeneration through Hydrogel-Enriched Chitosan Conduits Containing Engineered Schwann Cells for Drug Delivery. Cell Transplant [Internet]. 2016 Jan 15; 25 (1): 159-82. DOI: [PMid:25876520]
  7. Rochkind S, Mandelbaum-Livnat MM, Raimondo S, Morano M, Ronchi G, Viano N, et al. Peripheral Nerve Reconstruction Using Enriched Chitosan Conduits. In: Scaffolds in Tissue Engineering -Materials, Technologies and Clinical Applications [Internet]. InTech; 2017. DOI:
  8. Rochkind S, Almog M, Meilin S, Nevo Z. Reviving Matrix for Nerve Reconstruction in Rabbit Model of Chronic Peripheral Nerve Injury with Massive Loss Defect. Frontiers in Surgery (Accepted). 2020